Both natural and hybrid cyclic peptides represent an important class of molecules being actively explored as potential therapeutics.^[@ref1]^ These species are attractive because of their enhanced binding affinity, exo- and endopeptidase resistance, and in certain cases increased cell penetration compared to their linear counterparts. Chemical macrocyclization methods have been developed to cross-link two functional groups within a linear peptide substrate through head-to-tail, head-to-side chain, tail-to-side chain, or side chain-to-side chain.^[@ref2]^ Cross-linking methods include amide bond or ester bond formation,^[@ref3]^ thiol-based substitution with alkyl and benzyl halide electrophiles (commonly referred to as "alkylation"),^[@ref4]^ oxidation at cysteine or selenocysteine residues to form a dichalcogenide bond,^[@cit1a],[@ref5]^ native chemical ligation,^[@ref6]^ intein-mediated approaches,^[@ref7]^ Staudinger ligation,^[@ref8]^ transition-metal-catalyzed coupling reactions,^[@ref9]^ cycloadditions,^[@ref10]^ coordination-based approaches,^[@ref11]^ as well as several noncovalent strategies.^[@ref12]^

Enzyme-catalyzed peptide macrocyclizations remain rare.^[@ref13]^ Subtiligase was used to catalyze amide-bond formation between an *N*-terminal amine and a *C*-terminal ester to generate a 31-residue cyclic peptide with 85% yield.^[@ref14]^ Thioesterase was successfully employed to cyclize linear peptides generated from the nonribosomal peptide synthetase system.^[@ref15]^ Sortase was used to catalyze the cyclization of peptides, glycopeptides, and proteins.^[@ref16]^ With the sortase-catalyzed peptide cyclization method,^[@cit16a]^ a 67% yield of cyclic peptide product was produced and the linear oligomer was the major side product.

We recently reported a facile cysteine S~N~Ar arylation chemistry using highly activated and electrophilic perfluoroaromatic reagents.^[@ref17]^ In particular, two cysteine residues on an unprotected polypeptide were cross-linked with bifunctional perfluoroaromatic reagents. This macrocyclization strategy was versatile enabling the cross-linking of two cysteine moieties positioned at all sites ranging from *i, i*+1 to *i, i*+14 on a 14-residue unprotected peptide.^[@cit17b]^ For longer peptides, however, we found that entropic penalty becomes large enough to render macrocyclizations inefficient. This fundamental limitation is therefore expected to be encountered with any long and unstructured polypeptide irrespective of the cyclization chemistry used. To address the challenge associated with macrocyclization of long polypeptides, we now report a strategy where the glutathione *S*-transferase (GST) enzyme^[@ref18]^ is used to catalyze the S~N~Ar reaction between cysteine and perfluoroaromatic moieties in aqueous buffer leading to large hybrid peptide macrocycles. This transformation overcomes the major length restrictions previously encountered in noncatalyzed S~N~Ar macrocyclization reactions.

We have recently shown that GST can catalyze the conjugation of perfluoroaryl-linked biomolecules or chemical probes to polypeptides and proteins containing an *N*-terminal γ-Glu-Cys-Gly (GSH) tag.^[@ref19]^ This enzymatic "click" ligation reaction enables selective modification of the cysteine in the GSH tag in the presence of other cysteines and reactive functional groups on the same polypeptide chain. Importantly, we found that GST can catalyze the cyclization of a seven-residue peptide between an *N*-terminal GSH tag and a *C*-terminal perfluoroaryl moiety; intramolecular cyclization process occurred within seconds producing cyclic peptide in quantitative yield. This result suggests that one could in principle develop a general protocol for GST-catalyzed peptide macrocyclization for potentially larger ring sizes (Figure [1](#fig1){ref-type="fig"}).

![Glutathione *S*-transferase (GST)-catalyzed macrocyclization. The macrocyclic peptide is generated by GST-catalyzed S~N~Ar reaction between the cysteine thiol of an *N*-terminal glutathione (γ-Glu-Cys-Gly) tag and a perfluoroaryl moiety linked to the *C*-terminal cysteine. Circles represent amino acids.](ol-2014-01609y_0002){#fig1}

The linear substrates employed in our studies were readily prepared in two steps (Figure [2](#fig2){ref-type="fig"}). Peptides with an *N*-terminal disulfide protected GSH tag and a *C*-terminal free cysteine were synthesized by rapid flow-based Fmoc-SPPS followed by *C*-terminal cysteine *S*-arylation with perfluoroaromatic reagents using the previously reported protocol (see the [Supporting Information](#notes-1){ref-type="notes"}). The linear substrates were purified by RP-HPLC and then subjected to macrocyclization. Tris(carboxylethyl)phosphine hydrochloride (TCEP·HCl) was added to the reaction buffer in situ to deprotect the disulfide bond and generate a free cysteine in the GSH tag for GST-catalyzed macrocyclization.

We commenced our study by searching for the best perfluoroaromatic linker for the GST-catalyzed cyclization reaction (Figure [3](#fig3){ref-type="fig"}). We prepared model peptides **1a**--**c** with *C*-terminal cysteines *S*-arylated with decafluorobiphenyl, hexafluorobenzene, and pentafluorophenyl sulfide, respectively (Figure S1, [Supporting Information](#notes-1){ref-type="notes"}). Upon incubation of a 0.1 mM solution of peptide **1a** (Figure [3](#fig3){ref-type="fig"}B, top chromatogram) in the presence of 10 mol % of GST (0.2 mg/mL) in pH 8.0 phosphate buffer with 20 mM TCEP·HCl, cyclic product **Cyc-1a** was produced in quantitative yield within 5 min at room temperature as shown by LC--MS analysis of the crude reaction mixture. We did not observe oligomeric side products (Figure [3](#fig3){ref-type="fig"}B, bottom chromatogram). Importantly, the control reaction without added enzyme contained mostly unreacted linear peptide **1a**′ with only a trace amount of cyclized product (Figure [3](#fig3){ref-type="fig"}B, middle chromatogram). Compared with peptide **1a**, peptides **1b** and **1c** showed significantly lower enzyme mediated cyclization yields under the same reaction conditions (Figure [3](#fig3){ref-type="fig"}A). At extended reaction times, only 45% and 57% of cyclized products were observed for peptide **1b** and **1c** respectively (Figures S4 and S5, [Supporting Information](#notes-1){ref-type="notes"}).

![Synthesis of perfluoroaryl-linked peptides for GST-catalyzed macrocyclization. Circles represent amino acids. PG: protecting group; SPPS: solid-phase peptide synthesis.](ol-2014-01609y_0003){#fig2}

The highest cyclization rate under GST catalysis was achieved with peptide **1a** as determined by LC--MS time course studies (Figures S3 and S9, [Supporting Information](#notes-1){ref-type="notes"}). The cyclization rate of peptide **1a** under enzyme-catalysis was ∼900-fold faster than without enzyme (Figure S10, [Supporting Information](#notes-1){ref-type="notes"}). This high cyclization efficiency under enzyme catalysis permitted macrocyclization at increased concentrations of linear peptide: unlike other enzyme-catalyzed macrocyclization methods where increasing the concentrations of linear substrates can lead to the formation of oligomeric side products via competing intermolecular reaction pathways.^[@cit16a]^ We found that increasing the concentration of peptide **1a** to 10 mM with only 0.1 mol % of GST still produced the cyclized product quantitatively within 3 h (Figure S11, [Supporting Information](#notes-1){ref-type="notes"}); no oligomeric byproducts were observed. The unique preference and high efficiency of peptide **1a** for GST-catalyzed cyclization indicates the perfluorobiphenyl moiety is highly suited for this chemistry.

![Macrocyclization of peptides with different perfluoroaromatic linkers. Reaction conditions: 0.1 mM peptide **1a**--**c**, 0.2 mg/mL GST, 20 mM tris(carboxylethyl)phosphine hydrochloride (TCEP·HCl), 0.1 M phosphate, pH 8.0, room temperature (25 °C), 5 min. (A) Reaction yields with different linkers with or without the addition of GST. (B) LC--MS analysis of crude reaction mixtures with peptide **1a**. Amino acids are shown in one-letter codes. γ-E: γ-glutamic acid. LC--MS data shown are total ion currents (TIC); mass spectra at the highest points of the TIC peaks are shown as insets.](ol-2014-01609y_0004){#fig3}

![Macrocyclization of peptides with increasing lengths. Reaction conditions: 0.1 mM peptide **2a**--**4a**, 0.2 mg/mL GST, 20 mM TCEP·HCl, 0.1 M phosphate, pH 8.0, room temperature (25 °C), 2 h. (A) Reaction yields of cyclization reactions with and without the addition of GST (C(S-tBu): *tert*-butylthio-protected cysteine; C\*: perfluoroaryl-modified cysteine). The two cysteines that were cross-linked together are highlighted in red. (B) LC--MS analysis of reactions of peptide **2a** to **4a** with the addition of GST. LC--MS data shown are total ion currents (TIC); mass spectra at the highest points of the TIC peaks are shown as insets.](ol-2014-01609y_0005){#fig4}

To probe macrocyclization of peptides with increasing lengths, we prepared peptides **2a**--**4a** with variable numbers (2--4) of repeating GLKAG pentapeptide sequences positioned between the GSH tag and the perfluoroaryl-linked C-terminal cysteine (Figure S2, [Supporting Information](#notes-1){ref-type="notes"}). Although decreased cyclization rates were observed as the peptide lengths increased (Figure S10, [Supporting Information](#notes-1){ref-type="notes"}), cyclization of these three peptides under reaction conditions similar to those described in Figure [3](#fig3){ref-type="fig"} yielded cyclized products **Cyc-2a**--**Cyc-4a** nearly quantitatively within 2 h (Figure [4](#fig4){ref-type="fig"}). Only 5% of cyclic products were observed for reactions without GST present (Figure [4](#fig4){ref-type="fig"}A and Figures S6--S8, [Supporting Information](#notes-1){ref-type="notes"}).

To compare the GST-catalyzed macrocyclization in water with the uncatalyzed macrocyclization in organic solvent side-by-side, we prepared and purified peptides **2a**′--**4a**′ by reducing the disulfide moiety in peptides **2a**--**4a** and purified them by RP-HPLC (Figure S12, [Supporting Information](#notes-1){ref-type="notes"}). Adding DMF with Tris base to peptides **2a**′--**4a**′ initiated their intramolecular cyclization reaction and produced cyclized products **Cyc-2a**--**Cyc-4a**. The highest reaction yield was observed for the shortest peptide **2a**′ with 39% of cyclized product generated within 2 h as measured by LC--MS analysis of the crude reaction mixture (Figure S12B, [Supporting Information](#notes-1){ref-type="notes"}). Significant amounts of oligo- and polymeric side products were observed for the macrocyclizations of longer peptides **3a**′ and **4a**′; desired cyclic products were minor products identified in the LC--MS chromatograms (Figure S12, [Supporting Information](#notes-1){ref-type="notes"}).

To further compare the GST-catalyzed cyclization with our previously reported cross-linking chemistry,^[@cit17b]^ we synthesized peptides **2b**--**4b** with free cysteines at both the GSH tag and the *C*-terminus. Peptides **2b**--**4b** could be cyclized by the reaction with decafluorobiphenyl to produce **Cyc-2a**--**Cyc-4a**. Similar to peptide **2a**′--**4a**′, we observed decreased cyclization yields as the peptide lengths increased. 37% of desired product was formed with the shortest peptide **2b**, but no detectable cyclic product resulted with longer peptides **3b** and **4b** (Figure S14 and S13, [Supporting Information](#notes-1){ref-type="notes"}). We previously found reducing the concentration of linear substrate could improve the reaction yield of the cyclization reaction for small model peptides in DMF; however, cyclization of **3b** and **4b** at diluted conditions still resulted in mixtures of byproducts (Figure S13F,I, [Supporting Information](#notes-1){ref-type="notes"}).

In contrast to the GST-catalyzed cyclization where increasing the peptide length had no effects on the cyclization yield, all cyclization reactions in DMF showed significantly diminished yields as the peptide lengths increased (Figure S14, [Supporting Information](#notes-1){ref-type="notes"}). The significantly lowered reaction efficiencies and yields for macrocyclization in DMF compared to macrocyclization under GST catalysis in water highlight the effectiveness of the GST-catalyzed macrocyclization process which compensates the entropic penalty derived from the increased size of the peptide substrate.

Our previous studies have shown that the GST-catalyzed perfluoroarylation reaction was highly selective toward the cysteine residue within the GSH moiety.^[@ref19]^ The desired GSH *S*-arylated product could be selectively and quantitatively formed in the presence of another cysteine in the same polypeptide chain. We reasoned this highly selective nature of the GST-catalyzed reaction could permit the combination of GST-catalyzed ligation with native chemical ligation (NCL) to generate large cyclic peptides from linear substrate synthesized by NCL reaction (Figure [5](#fig5){ref-type="fig"}). GST selectively recognizes the GSH tag and only catalyzes the arylation reaction at the GSH thiol in the presence of the free cysteine generated from NCL reaction, thus allowing NCL product to be cyclized by GST-catalyzed ligation (Figure [5](#fig5){ref-type="fig"}).

We synthesized and purified a large 40-residue linear peptide **7** obtained from the hydrazide-based NCL reaction^[@ref21]^ (Figure S15, [Supporting Information](#notes-1){ref-type="notes"}). Cyclization of peptide **7** under GST catalysis produced desired cyclized product **Cyc-7** with 70% yield as measured by LC--MS analysis of the crude reaction mixture. Trypsin digestion and MS/MS analysis confirmed that the cysteine at the NCL ligation site remained unmodifed after the GST-catalyzed cyclization reaction (Figure S18, [Supporting Information](#notes-1){ref-type="notes"}). Reaction without enzyme showed only a trace amount of product formation and no regioselectivity (Figure S17, [Supporting Information](#notes-1){ref-type="notes"}). In addition, we further showed that the native chemical ligation and GST-catalyzed ligation could be done in one pot with the desired macrocyclic peptide as the major product (Figure S16, [Supporting Information](#notes-1){ref-type="notes"}). In most cases, the macrocyclic product ring size is restricted to lengths of peptides that can be accessed from SPPS and the efficiency of the cyclization reactions. In our method, combining GST-catalyzed ligation and native chemical ligation offers a method to overcome these challenges for the synthesis of large macrocyclic peptides.

![Macrocyclization of a 40-residue peptide **7** prepared from native chemical ligation. Reaction conditions: 0.1 mM peptide **7**, 0.2 mg/mL GST, 0.2 M phosphate, 20 mM TCEP·HCl, pH 8.0, room temperature, 2 h. LC--MS data shown are total ion currents of starting material (top chromatogram) and crude reaction mixture (bottom chromatogram); mass spectra at the highest points of the TIC peaks are shown as insets.](ol-2014-01609y_0006){#fig5}

We have shown how glutathione *S*-transferase (GST) can efficiently mediate the macrocyclization reaction of long peptides by catalyzing a S~N~Ar process between cysteine and perfluoroaromatic moieties. This transformation operates under mild aqueous conditions, at ambient temperature, and takes only a few hours to complete. The reaction was shown to be highly efficient and selective, especially for the generation of macrocyclic peptides with large ring sizes. To demonstrate the unique selectivity of our GST-catalyzed reaction, a 40-residue macrocyclic peptide was prepared by combining GST-catalyzed ligation with native chemical ligation.

Full experimental details and data. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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